Pushing the frontiers of drug delivery technology, a biomedical engineer at the University of Illinois at Chicago has developed an implantable capsule that releases a steady supply of insulin to the bloodstream of people with diabetes. The biocapsule, developed by Tejal Desai with support from the National Science Foundation (NSF), features two innovations designed to overcome previous obstacles. A biological process allows the capsule to continuously produce insulin, rather than using up a limited supply. The capsule is made of a material designed to overcome the problem of implant rejection.
The above story is based on materials provided by National Science Foundation. Note: Materials may be edited for content and length.
Cite This Page: